India News | Reported by Arvind Gunasekar, Edited by Chandrashekar Srinivasan | Monday July 6, 2020
More than 1,100 people are expected to be enrolled in the first two phases of human clinical trials for COVAXIN - India's first COVID-19 vaccine candidate, an application by developers Bharat Biotech said Friday. Phase I clinical trials are scheduled to start next week, with July 13 set as the date for participant enrolment. Results from Phase I wi...
www.ndtv.com